The Pharma & MedTech Market Access in Latin America Forum is focused on the challenges of satisfying Payer and HTA requirements across Latin America to achieve swift patient access. Featuring case studies from both Pharma, MedTech and the Payers themselves, this event is a must attend for all market access-responsible leaders within Life Sciences who consider this region a priority. This 2-day event will feature Pharma & MedTech-focused streams to ensure everyone learns the best market access strategy for their products and meets with key decision-makers from across the region.

Latin America’s rapidly expanding and maturing healthcare markets are undoubtedly a fantastic opportunity for pharmaceutical and medical device companies.
The reality, from a market access perspective, is that Latin America is a group of markets with vastly different market access environments. Several markets have well-established HTA and the infrastructure to carry this out; several markets are in the early stages of HTA implementation; several markets continue with International Reference Pricing and the remainder are a mixture of reimbursed and out-of-pocket payment healthcare markets. With a strong and growing private insurer market superimposed on top of all this, the complexity of this region requires a complex solution.

Pharmaceutical and medical device companies need to use a variety of market access approaches to bring their products to these dynamic markets. A one size- fits-all approach is destined to fail and fit-for-purpose local expertise is essential to deliver the appropriate value message to the appropriate stakeholders in each market.

This 2 day event features key decision-makers and industry experts from both Pharma & MedTech sectors (in focused streams) to bring attendees an insight-filled event. With plenty of networking opportunities to meet with the LATAM region’s payers & HTAs and experts from industry, this meeting will allow attendees to ensure their market access strategy is optimized for their specific product type.

Why Attend?

  1. Learn how to demonstrate product value to local HTA agencies, regulators and payers.
  2. Hear multiple perspectives from all stakeholders such as the pharmaceutical and medical device industries, academia, HTAs, regulators and payers.
  3. View the potential picture of regulatory changes, market growth and market access in Latin America.
  4. Appreciate different market approaches and barriers to market access from the industry perspective.
  5. Understand the market’s affordability and willingness to reimburse innovative, high-cost drugs.
  6. Develop your strategy to become a partner with your customers, not simply a supplier.
  7. Benchmark, network and co-operate with pharma, device & senior-level decision makers in the region.

    Payers & HTA Agencies

    Director of Health Regulation
    ANVISA, Brazil

    Director of Innovation and Technological Development
    Social Security Institute, Mexico

    Head
    NATS-INC, The National Institute for Cardiology
    Ministry of Health, Brazil

    Former Deputy Director of Health Technology Assessment
    Instituto de Evaluación Tecnológica en Salud – IETS, Colombia

    Technical Director
    United Healthcare / Amil, Brazil

    Director, Department of Chronic Diseases
    South American Center of Excellence for Cardiovascular Health (CESCAS)
    Institute for Clinical Effectiveness and Health Policy (IECS), Argentina

    Chief Financial Officer
    National Resources Fund, Uruguay

    Medical Auditor, Head of Oncology Unit
    UNIMED, Brazil

     

    Industry Experts – Pharmaceuticals

    Chair-Elect
    ISPOR Latin America Consortium, Colombia

    Pricing & Access Regional Director Latin America & Canada (LACan)
    Novartis, Switzerland

    Director of Corporate Affairs
    Novartis, Brazil

    Regional Epidemiology and Real-World Evidence Lead
    GSK, Brazil

    President
    CSL Behring, Brazil

    HTA & Policy Reimbursement Lead
    Roche, Latin America

     

    Industry Experts – MedTech

    CEO
    ABIMED (Brazilian Association of High Technology Industry for Medical Equipment, Products and Supplies)

    Director, Market Access, Government & Public Affairs
    Medtronic, Brazil

    Medical Value & Access Director
    Roche Diagnostics, Brazil

    Director, Market Access, EMEA, Canada & LATAM
    Edwards Lifesciences, Switzerland

    Health Economics & Market Access Senior Manager 
    Johnson & Johnson Medical Devices, Brazil

     

    Experienced Solution Providers

    Managing Director
    Value Connected, Netherlands

    Senior Vice President
    CB Partners, USA

    Director of Business Operations, Latin America
    ValueConnected, Brazil

     

     

    Pictures from recent Market Access Leaders Forums. Imagine being there...

    Speaker List - Day 1

    Former Deputy Director of Health Technology Assessment
    Instituto de Evaluación Tecnológica en Salud – IETS, Colombia

    Director of Health Regulation
    ANVISA, Brazil

    Director of Innovation and Technological Development
    Social Security Institute, Mexico

    Director, Department of Chronic Diseases
    South American Center of Excellence for Cardiovascular Health (CESCAS)
    Institute for Clinical Effectiveness and Health Policy (IECS), Argentina

    Head
    NATS-INC, The National Institute for Cardiology
    Ministry of Health, Brazil

    Technical Director
    United Healthcare / Amil, Brazil

    Managing Director
    Value Connected, Netherlands

    Chief Financial Officer
    National Resources Fund, Uruguay

    Chair-Elect
    ISPOR Latin America Consortium, Colombia

    Director of Corporate Affairs
    Novartis, Brazil

    Medical Value & Access Director
    Roche Diagnostics, Brazil

    Speaker List - Day 2 - Stream 1

    Chair-Elect
    ISPOR Latin America Consortium, Colombia

    Pricing & Access Regional Director Latin America & Canada (LACan)
    Novartis, Switzerland

    Director of Corporate Affairs
    Novartis, Brazil

    Director of Business Operations, Latin America
    ValueConnected, Brazil
     

    Medical Auditor, Head of Oncology Unit
    UNIMED, Brazil

    HTA & Policy Reimbursement Lead
    Roche, Latin America

    Regional Epidemiology and Real-World Evidence Lead
    GSK, Brazil

    President
    CSL Behring, Brazil

    Speaker List - Day 2 - Stream 2

    Director, Market Access, Government & Public Affairs
    Medtronic, Brazil

    Director, Market Access, EMEA, Canada & LATAM
    Edwards Lifesciences, Switzerland

    CEO
    ABIMED (Brazilian Association of High Technology Industry for Medical Equipment, Products and Supplies)

    Medical Value & Access Director
    Roche Diagnostics, Brazil

    Medical Auditor, Head of Oncology Unit
    UNIMED, Brazil

    Health Economics & Market Access Senior Manager 
    Johnson & Johnson Medical Devices, Brazil

    Managing Director
    Value Connected, Netherlands

     

     

    This event will provide all delegates the chance to meet one another through our many networking opportunities. With pre-event, mid-morning and mid-afternoon breaks as a standard, this event will also feature a complimentary networking dinner for all participants.

    This evening will allow you to meet with our expert speaker panel who represent many stakeholder groups in a less formal setting. Our networking lunches will also allow you plenty of time to meet with your peers and colleagues whilst you refuel through the event.

    Pharmaceutical and Medical Device Companies:

    Vice-Presidents, Directors, Managers involved in: Market Access, Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Country Managers

    Solution providers & consultants:
    CEOs, Business Development, Senior Consultants, Regional Heads

    Plus:Independent Academics, Health Economists, Senior Doctors, & Patient Representatives.

    Event Partners

    Media Partners

    This event is accredited for CPD (Continuing Professional Development) status

    Share with Colleagues